Charles T. Nomides
Geen lopende functies
Profiel
Charles T.
Nomides was appointed Chief Research and Development Officer for Barrier Therapeutics, Inc. in February 2006.
From July 2002 to February 2006, he served as Chief Operating Officer of Barrier Therapeutics.
From 1997 to 2002, he was employed by Johnson & Johnson Consumer Products Worldwide, where he served as Director of Research and Development in charge of the Ortho Neutrogena Prescription Drug Development Group.
Mr. Nomides received a Bachelor's degree in Biology from Clarion State University and graduate training from Temple University and The Milton S.
Hershey Medical Center.
Eerdere bekende functies van Charles T. Nomides
| Bedrijven | Functie | Einde |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Hoofd Techniek/Wetenschap/O&O | 13-09-2007 |
Johnson & Johnson Consumer Products Co.
 Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 |
Opleiding van Charles T. Nomides
| Clarion University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Johnson & Johnson Consumer Products Co.
Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Consumer Non-Durables |
